✦ LIBER ✦

The preclinical evaluation of angiogenesis inhibitors

✍ Scribed by Michael S. O'Reilly

Book ID: 110228987
Publisher: Springer US
Year: 1997
Tongue: English
Weight: 54 KB
Volume: 15
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1005762410476

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical and clinical evaluation of f

Preclinical and clinical evaluation of farnesyltransferase inhibitors

✍ Charles Baum; Paul Kirschmeier 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 547 KB

The history of angiogenesis inhibitors

✍ Ribatti, D 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 77 KB

Angiogenesis inhibitors: motivators of m

Angiogenesis inhibitors: motivators of metastasis?

✍ Steeg, Patricia S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 306 KB

Clinical translation of angiogenesis inh

Clinical translation of angiogenesis inhibitors

✍ Kerbel, Robert; Folkman, Judah 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 793 KB

Preclinical and clinical evaluation of p

Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer

✍ Julian Adams 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 824 KB

The proteasome is a multicatalytic protease, present in all eukaryotic cells, that is primarily responsible for intracellular protein degradation. By destroying regulatory proteins or their inhibitors, the proteasome influences many cellular regulatory signals and is thus a potential target for phar

Mechanisms of tumor angiogenesis and the

Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors

✍ Hugues Malonne; Ingrid Langer; Robert Kiss; Ghanem Atassi 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 154 KB